Just this past Monday, an article appeared in the New York Times, which discussed the implications of the Physician Payment Sunshine Act including the predicted affect it will have on the medical industry. http://www.nytimes.com/2012/01/17/health/policy/us-to-tell-drug-makers-to-disclose-payments-to-doctors.html
As a leader in travel and expense management automation, we have to be prepared when new regulations, such as these, are unveiled that affect the way in which we report customer data.
Will you be affected by this new government regulation or have thoughts on the topic? Let us know!